Holen Sie sich die Stockscreener-App
8.085
1.46%
-0.115
Handel nachbörslich:
8.08
-0.005
-0.06%
Schlusskurs vom Vortag:
$8.20
Offen:
$8.08
24-Stunden-Volumen:
694.28K
Relative Volume:
0.62
Marktkapitalisierung:
$707.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-6.125
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+1.13%
1M Leistung:
+11.76%
6M Leistung:
+249.78%
1J Leistung:
+6.04%
1-Tages-Spanne:
$7.91
$8.1965
1-Wochen-Bereich:
$7.91
$8.6214
52-Wochen-Spanne:
$1.865
$8.7799
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
8.085 | 717.59M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Neutral |
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
How Terns Pharmaceuticals Inc. stock valuations compare to rivalsEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Tick level data insight on Terns Pharmaceuticals Inc. volatilityTrade Analysis Summary & Low Risk Entry Point Tips - newser.com
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceJuly 2025 WrapUp & Verified Chart Pattern Signals - newser.com
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
What analysts say about Terns Pharmaceuticals Inc stockMean Reversion Trades & Secret Picks Wall Street Isn’t Talking About - earlytimes.in
Detecting price anomalies in Terns Pharmaceuticals Inc. with AIPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Using data models to predict Terns Pharmaceuticals Inc. stock movementQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Is it too late to sell Terns Pharmaceuticals Inc.2025 Year in Review & High Accuracy Trade Alerts - newser.com
Terns Pharmaceuticals Inc Stock Analysis and ForecastCup and Handle Formations & Interactive Charts for Smarter Trading - earlytimes.in
How to recover losses in Terns Pharmaceuticals Inc. stockWeekly Stock Recap & Growth Focused Entry Reports - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Predicting Terns Pharmaceuticals Inc. trend using moving averages2025 Key Lessons & Fast Gain Stock Tips - newser.com
Volume spikes in Terns Pharmaceuticals Inc. stock – what they meanJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ... - Enidnews.com
118,000-share grant: Terns Pharmaceuticals awards inducement options at $7.81 with 10-year term - Stock Titan
MarketsMedicine Hat News - FinancialContent
Does Terns Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely - Yahoo Finance
Terns Pharmaceuticals: Valued As If It Can't Win - Seeking Alpha
Is Terns Pharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Yield Stock Picks - earlytimes.in
Will Terns Pharmaceuticals Inc. stock see insider buyingDollar Strength & Daily Entry Point Alerts - The British Mountaineering Council
Exchange Traded Concepts LLC Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Full technical analysis of Terns Pharmaceuticals Inc. stockTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Goldman Sachs Group Inc. Has $1.15 Million Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Technical analysis overview for Terns Pharmaceuticals Inc. stockWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Can Terns Pharmaceuticals Inc. rally from current levels2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
2 Under-the-Radar Stocks That Could Soar - Mitrade
Fed Meeting: Is Terns Pharmaceuticals Inc a top pick in the sectorJuly 2025 Opening Moves & Fast Gain Swing Alerts - خودرو بانک
Aug Wrap: Is Terns Pharmaceuticals Inc stock a good dividend stockWeekly Stock Analysis & Fast Exit Strategy with Risk Control - خودرو بانک
Analyzing Terns Pharmaceuticals Inc. with multi timeframe charts2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
How high can Terns Pharmaceuticals Inc. stock goQuarterly Portfolio Report & Consistent Return Strategy Ideas - newser.com
Published on: 2025-09-19 23:29:17 - خودرو بانک
Profit Review: Will Terns Pharmaceuticals Inc benefit from current market trendsJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک
Trend analysis for Terns Pharmaceuticals Inc. this weekBreakout Watch & Real-Time Volume Analysis Alerts - newser.com
Identifying reversal signals in Terns Pharmaceuticals Inc.Quarterly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Statistical indicators supporting Terns Pharmaceuticals Inc.’s strength2025 Price Targets & Smart Swing Trading Techniques - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans - 富途牛牛
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):